01.10.2012 | Original Article
A population pharmacokinetic/pharmacodynamic model of thrombocytopenia characterizing the effect of trastuzumab emtansine (T-DM1) on platelet counts in patients with HER2-positive metastatic breast cancer
Erschienen in: Cancer Chemotherapy and Pharmacology | Ausgabe 4/2012
Einloggen, um Zugang zu erhalten